Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."

OTCPK:EMMBF - Post Discussion

Emblem Corp > EMC Warrants
View:
Post by DelicateBalance on May 08, 2018 9:44am

EMC Warrants

EMBLEM CORP EMC.WT $1.75 12/6/2019
EMBLEM CORP EMC.WT.A $2.15 11/21/2020
EMBLEM CORP EMC.WT.B $2.70 2/2/2020

I am underwater on the WT series, average about 0.70, exercise price $1.75, December 6, 2019. The large spreads and thin volumes make them nearly impossible to trade. Dead money, for now anyway. 

Anyone else looking at the warrants?
Comment by Pumperknicle on May 08, 2018 1:45pm
I've got a bunch of the WT & WT.B...I like the upside potential of warrants...I bought them to hold as they have no acceleration provision...they will become much more liquid as the share price goes up.
Comment by gkmackdadzzz1 on May 08, 2018 2:23pm
This post has been removed in accordance with Community Policy
Comment by deminimis on May 08, 2018 2:54pm
400K came from wholesaling to other LPs. Growwise was probably around 220K so that leaves about 580K from patient sales. I am going to guess around 120K of that was from oil sales. I think oil sales will have a more meaningful impact in Q2.